STAT-Mediated TGFalpha EGFR Signaling in squamous cell carcinoma of head neck
STAT-Mediated TGFalpha EGFR Signaling in squamous cell carcinoma of head neck
批准号:
7253419
负责人:
Jennifer Rubin Grandis
金额:
$26.27万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-08-01 至 2008-06-30
关键词:
AddressApoptosisAutocrine CommunicationBindingCell NucleusCellsComplexCytosolDNAEpidermal Growth Factor ReceptorEpithelial CellsGene MutationGoalsGrowthHead and Neck CancerHead and Neck NeoplasmsHead and Neck Squamous Cell CarcinomaHead and neck structureIn VitroIntracellular Signaling ProteinsInvestigationJanus kinaseLigandsLinkMediatingOncogenicPathway interactionsPatientsPeripheral Blood LymphocytePhosphotransferasesProtein IsoformsReceptor SignalingRegulatory PathwayReportingRoleSTAT proteinSamplingSignal PathwaySquamous cell carcinomaStat3 proteinSystemTestingTransforming Growth Factor alphaTumor Suppressor ProteinsTyrosine Phosphorylationautocrinecell growthdesignin vivomutantnovelprognosticreceptorreceptor functionsrc-Family Kinasestumortumor growthtumorigenesis
中文摘要
描述(由申请人提供):信号转导和转录激活因子(STATs)是细胞内信号蛋白,在酪氨酸磷酸化时被激活,并从细胞质转移到细胞核,在细胞核中它们与DNA的特定区域结合并发挥转录活性。我们已经积累了令人信服的证据,表明stat3和5在头颈部鳞状细胞癌(SCCHN)中的组成性激活代表了SCCHN的关键生存途径,而Stat1的激活抑制肿瘤生长。我们最近报道,靶向Stat5b而非Stat5a可抑制体外SCCHN生长。初步研究结果表明Stat5b激活与体内SCCHN肿瘤发生有关。构成型STAT激活的潜在原因包括上游受体和非受体激酶的自分泌刺激。在此之前,我们已经证明在SCCHN中EGFR刺激后STATs被激活。进一步的研究表明Src家族激酶参与了这些细胞中EGFR/STAT的激活机制。因此,我们提出验证SCCHN生长控制丧失是通过获得tgf - α /EGFR自分泌信号通路介导的假设,该信号通路是由STATs的选择性激活介导的,最终目的是设计针对这些通路的新治疗策略。为了实现这一更新应用的目标,我们将:1)检查Stat5亚型在正常和转化的粘膜鳞状上皮细胞中的差异功能;2)确定Src激酶在SCCHN中egfr介导的STAT信号通路中的作用;3)确定Stat1在SCCHN中作为肿瘤抑制因子的作用机制。
英文摘要
DESCRIPTION (provided by applicant): Signal Transducers and Activators of Transcription (STATs) are intracellular signaling proteins that are activated upon tyrosine phosphorylation and translocate from the cytosol to the nucleus where they bind to specific regions of DNA and exert transcriptional activity. We have accumulated convincing evidence that constitutive activation of STATs 3 and 5 in squamous cell carcinoma of the head and neck (SCCHN) represent critical survival pathways in SCCHN, whereas Stat1 activation inhibits tumor growth. We recently reported that targeting Stat5b, but not Stat5a, abrogated SCCHN growth in vitro. Results of preliminary studies demonstrate that Stat5b activation is linked to SCCHN tumorigenesis in vivo. Potential causes of constitutive STAT activation include autocrine stimulation of upstream receptor and non-receptor kinases. Previously, we have shown that STATs are activated following stimulation of EGFR in SCCHN. Further investigation implicates Src family kinases in EGFR/STAT activation mechanisms in these cells. Therefore, we propose to test the hypothesis that loss of growth control in SCCHN is mediated through acquisition of a TGF-alpha/EGFR autocrine signaling pathway that is mediated by selective activation of STATs, with the ultimate aim of designing novel treatment strategies to target these pathways. To accomplish the goals of this renewal application, we will: 1) examine the differential function of Stat5 isoforms in normal and transformed mucosal squamous epithelial cells; 2) determine the role of Src kinases in EGFR-mediated STAT signaling pathways in SCCHN; and 3) determine the mechanisms by which Stat1 functions as a tumor suppressor in SCCHN.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeting STAT3 to enhance anti-tumor immunity
-
批准号:10405428
-
项目类别:
-
资助金额:$63.0万
-
财政年份:2019
-
负责人:Jennifer Rubin Grandis
-
依托单位:
Targeting STAT3 to enhance anti-tumor immunity
-
批准号:10621927
-
项目类别:
-
资助金额:$63.64万
-
财政年份:2019
-
负责人:Jennifer Rubin Grandis
-
依托单位:
Integrating genomics and the protein interactome for HPV+ head and neck cancer therapy
-
批准号:9982266
-
项目类别:
-
资助金额:$77.0万
-
财政年份:2018
-
负责人:Jennifer Rubin Grandis
-
依托单位:
Integrating genomics and the protein interactome for HPV+ head and neck cancer therapy
-
批准号:10664975
-
项目类别:
-
资助金额:$94.96万
-
财政年份:2018
-
负责人:Jennifer Rubin Grandis
-
依托单位:
Integrating genomics and the protein interactome for HPV+ head and neck cancer therapy
-
批准号:9764300
-
项目类别:
-
资助金额:$93.46万
-
财政年份:2018
-
负责人:Jennifer Rubin Grandis
-
依托单位:
Integrating genomics and the protein interactome for HPV+ head and neck cancer therapy
-
批准号:10224700
-
项目类别:
-
资助金额:$96.9万
-
财政年份:2018
-
负责人:Jennifer Rubin Grandis
-
依托单位:
Integrating genomics and the protein interactome for HPV+ head and neck cancer therapy
-
批准号:10456330
-
项目类别:
-
资助金额:$94.96万
-
财政年份:2018
-
负责人:Jennifer Rubin Grandis
-
依托单位:
Clinical and Translational Science Institute
-
批准号:9341569
-
项目类别:
-
资助金额:$41.47万
-
财政年份:2016
-
负责人:Jennifer Rubin Grandis
-
依托单位:
Clinical and Translational Science Institute
-
批准号:9317561
-
项目类别:
-
资助金额:$1702.44万
-
财政年份:2016
-
负责人:Jennifer Rubin Grandis
-
依托单位:
PI3K Pathway Mutations in Head and Neck Cancer
-
批准号:10398070
-
项目类别:
-
资助金额:$63.47万
-
财政年份:2014
-
负责人:Jennifer Rubin Grandis
-
依托单位:
GPCR Signaling in SCCHN: Integration with EGFR
-
批准号:8606299
-
项目类别:
-
资助金额:$27.72万
-
财政年份:2014
-
负责人:Jennifer Rubin Grandis
-
依托单位:
GPCR Signaling in SCCHN: Integration with EGFR
-
批准号:9276624
-
项目类别:
-
资助金额:$28.96万
-
财政年份:2014
-
负责人:Jennifer Rubin Grandis
-
依托单位:
PI3K Pathway Mutations in Head and Neck Cancer
-
批准号:10624224
-
项目类别:
-
资助金额:$64.11万
-
财政年份:2014
-
负责人:Jennifer Rubin Grandis
-
依托单位:
PI3K Pathway Mutations in Head and Neck Cancer
-
批准号:8826099
-
项目类别:
-
资助金额:$34.32万
-
财政年份:2014
-
负责人:Jennifer Rubin Grandis
-
依托单位:
GPCR Signaling in SCCHN: Integration with EGFR
-
批准号:9009250
-
项目类别:
-
资助金额:$28.93万
-
财政年份:2014
-
负责人:Jennifer Rubin Grandis
-
依托单位:
PI3K Pathway Mutations in Head and Neck Cancer
-
批准号:8639782
-
项目类别:
-
资助金额:$39.4万
-
财政年份:2014
-
负责人:Jennifer Rubin Grandis
-
依托单位:
PI3K Pathway Mutations in Head and Neck Cancer
-
批准号:9978809
-
项目类别:
-
资助金额:$64.53万
-
财政年份:2014
-
负责人:Jennifer Rubin Grandis
-
依托单位:
Research Workshop on the Biology, Prevention and Treatment of Head and Neck Cance
-
批准号:8002297
-
项目类别:
-
资助金额:$2.0万
-
财政年份:2010
-
负责人:Jennifer Rubin Grandis
-
依托单位:
SPORE in Head and Neck Cancer
-
批准号:7910938
-
项目类别:
-
资助金额:$23.06万
-
财政年份:2009
-
负责人:Jennifer Rubin Grandis
-
依托单位:
Clinical and Transtional Science Institute
-
批准号:8737325
-
项目类别:
-
资助金额:$285.85万
-
财政年份:2006
-
负责人:Jennifer Rubin Grandis
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: